Coagulation disorders.
D000028:Abortion, Induced / Q000009:adverse effects; D000037:Abruptio Placentae / Q000150:complications; D000925:Anticoagulants / Q000009:adverse effects; D001777:Blood Coagulation; D001778:Blood Coagulation Disorders / Q000188:drug therapy / Q000209:etiology*; D004211:Disseminated Intravascular Coagulation / Q000209:etiology; D004619:Embolism, Amniotic Fluid / Q000150:complications; D005169:Factor VIII / Q000032:analysis; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000652:urine; D005340:Fibrinogen / Q000032:analysis; D005342:Fibrinolysis; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D011225:Pre-Eclampsia / Q000097:blood / Q000150:complications; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000209:etiology*
D000925:Anticoagulants; D005338:Fibrin Fibrinogen Degradation Products; D005169:Factor VIII; D005340:Fibrinogen; D006493:Heparin